Mark L. Perry

In 2020, Mark L. Perry concentrated 38 of the 61 filings, nearly all tied to sales at Nvidia Corp. In all, 38 sales for EUR 38.7 million and a median of EUR 328,151. The largest are the most recent: EUR 11,035,517 on February 23, 2024, EUR 5,771,676 on April 2, 2024 and EUR 3,219,497 on February 12, 2018.

A single purchase sits in the record, of EUR 92,773 on August 17, 2015 at Global Blood Therapeutics, Inc.; it makes up 3% of the market trades. The record covers transactions from August 17, 2015 to April 2, 2024, at Nvidia (43 filings), Global Blood Therapeutics (15) and MyoKardia, Inc. (3), always as a director. It adds 8 share grants, 10 option exercises and 4 filings of another kind.

No filing falls in the last twelve months. Filings are published a median of 2 days after the transaction.

Perry has 27, 25 and 17 own market trades within 30 days of colleagues at Nvidia Corp, in that order. All of them in the same direction. Colleagues in order: Persis Drell, A. Brooke Seawell and Tench Coxe.